2 results match your criteria: "UNC Hospitals 101 Manning Dr. 4th Floor[Affiliation]"
Correction to: Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review.
Matern Health Neonatol Perinatol
July 2019
1Division of Pediatrics, University of North Carolina at Chapel Hill, UNC Hospitals 101 Manning Dr. 4th Floor, Chapel Hill, NC CB 7596 USA.
[This corrects the article DOI: 10.1186/s40748-018-0092-2.].
View Article and Find Full Text PDFAssociation between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review.
Matern Health Neonatol Perinatol
November 2018
1Division of Pediatrics, University of North Carolina at Chapel Hill, UNC Hospitals 101 Manning Dr. 4th Floor, Chapel Hill, NC CB 7596 USA.
Furosemide is a potent loop diuretic commonly and variably used by neonatologists to improve oxygenation and lung compliance in premature infants. There are several safety concerns with use of furosemide in premature infants, specifically the risk of sensorineural hearing loss (SNHL), and nephrocalcinosis/nephrolithiasis (NC/NL). We conducted a systematic review of all trials and observational studies examining the association between these outcomes with exposure to furosemide in premature infants.
View Article and Find Full Text PDF